News for Dyadic International, Inc. (DYAI)

JUPITER, Fla., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (”œDyadic”, ”œwe”, ”œus”, ”œour”, or the ”œCompany”) ( DYAI), a bio

**media[506840]**

California-based clinical-stage biopharmaceutical company Revelation Biosciences, Inc. (REVB) is up over 125 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable Therapeutics JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyad

Dyadic International, Inc. (NASDAQ:DYAI) Q3 2024 Earnings Conference Call November 12, 2024 5:00 PM ETCompany ParticipantsPing Rawson - CFOMark Emalfarb -...

Revenue: Increased to approximately $1.96 million for Q3 2024, significantly surpassing the analyst estimate of $1.10 million, driven by license revenue and mi

Dyadic International Inc (DYAI) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 2024 revenue is $1.10 million, and the ear

Dyadic to Report Third Quarter 2024 Financial Results on  Tuesday, November 12, 2024

**media[456050]**

Revenue: Decreased to approximately $386,000 from $837,000 year-over-year.Cost of Research and Development Revenue: Decreased to approximately $302,000 from $7

Singapore-based Sound Group Inc. (SOGP), an audio-centric social and entertainment company is up over 102% in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce its 12th Annual Discovery One-on-One Investor Conference to be...

TORONTO, Ontario, Sept. 29, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nerds On Site Inc. (CSE: NERD), a cybersecurity and mobile IT solutions company...

NEW YORK, Nov. 22, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- RHK Capital (“RHK”) will host the 2022 Disruptive Growth Conference on December 5-6,...

Niche Companies in Tech, Pharma, Cannabis, Finance and more in Attendance...

KUALA LUMPUR: Biotechnology company, Dyadic International Inc (Dyadic) is expanding its partnership with South Korea’s Medytox Inc (Medytox) to co-dev...

Dyadic and Medytox To Develop Vaccines Against COVID-19 Variants GlobeNewswire March 23, 2021 Expanding existing COVID-19 vaccine research collaboration which began in July 2020.Medytox and Dyadic to co-develop C1 enabled COVID-19 vaccines and/or boosters which will immunize people against two or more of the current and future COVID-19 variants (e.g., tetravalent or...